Matthew B. Klein, CEO: PTC Therapeutics PTCT Sell · Filed 23/04/20

Trade details

Type: Insider sale
Amount: $63,020.44
Shares · price: 1,211 sh · $52.04 a share
Held after: 102,645 sh
Stock: PTC Therapeutics PTCT
Person: Matthew B. KleinCEO
Trade date: 23/04/18
Filed: 23/04/20
Days to filing: 2 days

Sold 1.2% of holdings

Share of holding sold: 1.2%

PTC Therapeutics trades, last 26 weeks

What else happened in PTC Therapeutics around then

Filed or reported within 30 days of the trade day · 23/03/19~23/05/18

Matthew B. Klein's recent trades

Matthew B. KleinOfficer, Director
Planned salePTC Therapeutics
Planned sale
PTC Therapeutics
PTCT
$705.8K
10,292 sh
$705.8K
Filed 08/04
Traded 08/04
Matthew B. KleinDirector
SellClearPoint Neuro
Sell
ClearPoint Neuro
CLPT
$185.4K
16,000 sh
$185.4K
Filed 05/26
Traded 05/21
Matthew B. KleinDirector
Planned saleClearPoint Neuro
Planned sale
ClearPoint Neuro
CLPT
$185.4K
16,000 sh
$185.4K
Filed 05/21
Traded 05/21
Matthew B. KleinCEO
Sell10b5-1 planPTC Therapeutics
Sell10b5-1 plan
PTC Therapeutics
PTCT
$527.7K
7,221 sh
$527.7K
Filed 05/15
Traded 05/14
Matthew B. KleinCEO
Sell10b5-1 planPTC Therapeutics
Sell10b5-1 plan
PTC Therapeutics
PTCT
$186.4K
2,572 sh
$186.4K
Filed 05/15
Traded 05/14